Technology Commercialization

 

2021 - IMDX SARS-CoV2 Multiplex RT-PCR Assays. Two Assays Licensed to Siemens Healthcare Private Limited.


2020 - COVIDsure Multiplex Realtime RT-PCR kit. Licensed to Trivitron Healthcare Pvt Ltd, India.


2018 - Molecular diagnostic assays for 27 genetic diseases. Licensed to Dr Lal Path Lab Ltd, India.


2016 - Next Generation Sequencing based approach for diagnosis of Mitochondrial Disorders. Licensed to Eurofins Clinical Genetics India Ltd and marketed in the brand name MitoSure.